Accelerate Diagnostics reported $66.27M in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Accelerate Diagnostics AXDX:US USD 66.27M 18.21M
Becton, Dickinson and BDX:US USD 8.18B 34M
Bio Rad Laboratories BIO:US USD 3.14B 109.54M
Bruker BRKR:US USD 2.04B 50.9M
Danaher DHR:US USD 15.88B 1.63B
Exact Sciences EXAS:US USD 1.05B 53.13M
Hologic HOLX:US USD 4.02B 159.2M
Illumina ILMN:US USD 2.49B 404M
Meridian Bioscience VIVO:US USD 210.6M 1.87M
Myriad Genetics MYGN:US USD 352.3M 14.8M
Nanostring Technologies NSTG:US USD 318.71M 35.99M
Pacific Biosciences Of California PACB:US USD 913.9M 56.39M
Perkinelmer PKI:US USD 3.12B 1.01B
Quidel QDEL:US USD 1.45B 113.9M
Thermo Fisher Scientific TMO:US USD 25.36B 6.07B